|Title:||An Asian Patient with Intraocular Lymphoma Treated by Intravitreal Methotrexate||Authors:||WANG, JIA-KANG
LO, ANDY Y.
|Keywords:||chemotherapy;intraocular lymphoma;intravitreal injection;methotrexate;primary central nervous system lymphoma||Issue Date:||2006||Journal Volume:||v.50||Journal Issue:||n.5||Start page/Pages:||474-478||Source:||JAPANESE JOURNAL OF OPHTHALMOLOGY||Abstract:||
Background: To demonstrate the efficacy of intravitreal methotrexate for treating intraocular lymphoma. Case: A 55- year-old immunocompetent Asian man was diagnosed with intraocular lymphoma. Observations: The patient was initially managed by intravenous administration of high-dose methotrexate . Because vitreous cells persisted after systemic chemotherapy, methotrexate was given intravitreally thereafter. There was only self- limited corneal epitheliopathy without major complications following intraocular injections. Ocular remission was sustained during a 21-month follow-up. Conclusion: Intravitreal methotrexate is an effective, repeatable, and safe treatment for intraocular lymphoma.
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.